Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy to treat severely calcified cardiovascular disease, announced that the Centers for Medicare & Medicaid Services granted approval for a Transitional Pass-Through payment for Shockwave C2 Coronary IVL device, effective July 1, 2021.
June 11, 2021
· 5 min read